Cilastatin is a medicine used with another antibiotic called imipenem. It helps the imipenem work better by preventing the body from breaking it down too quickly in the kidneys. This allows more of the antibiotic to stay in your body longer, helping to fight infections.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Cilastatin is a partner drug for imipenem, a powerful intravenous antibiotic from the carbapenem family. Cilastatin is not an antibiotic itself. It is always given in the same infusion as imipenem, so people usually meet it under the combined name imipenem and cilastatin, or the brand Primaxin. Primaxin and its generic versions are used in hospitals for serious bacterial infections, including pneumonia and other lower lung infections, complicated urinary tract infections, infections inside the abdomen, gynecologic infections, bloodstream infections, bone and joint infections, skin infections and some heart valve infections (endocarditis). It is not used for meningitis, and it is not recommended for brain or spinal cord infections in children because of the risk of seizures. A second product, Recarbrio, adds a third ingredient, relebactam, which blocks enzymes some bacteria use to destroy antibiotics. Recarbrio treats pneumonia that develops in the hospital or on a ventilator, and complicated urinary or abdominal infections in people who have few or no other treatment options. Both products are reserved for infections that are proven or strongly suspected to be bacterial, to slow the spread of antibiotic resistance.
Imipenem kills bacteria by stopping them from building their cell walls. On its own, though, much of it would be broken down in the kidneys by an enzyme called dehydropeptidase I, leaving relatively little active drug in the urine. Cilastatin blocks that enzyme. Given together, the two drugs keep imipenem intact long enough to reach effective levels in the blood and urine, which matters especially for urinary tract infections. In Recarbrio, relebactam adds a further layer of protection: it disables certain bacterial enzymes (beta-lactamases) that would otherwise inactivate imipenem, extending the combination to some resistant germs.
Imipenem and cilastatin is given as an intravenous (IV) infusion, usually in a hospital, often every 6 or 8 hours. Each dose drips in over about 20 minutes to an hour depending on its size. The dose is written as the amount of imipenem, with an equal amount of cilastatin in the same bag. Recarbrio is typically given every 6 hours as a 30-minute infusion. The care team chooses the dose based on the likely bacteria, body weight in children, and kidney function. Lower doses are used when the kidneys filter less well, because the drugs build up and the seizure risk rises. People with very poor kidney function generally receive it only if dialysis is planned. If nausea starts during an infusion, the nurse can slow the drip.
The most common problems are irritation or soreness of the vein where the IV runs, nausea, vomiting, diarrhea, rash and itching. Fever and a drop in blood pressure can also occur. Most of these are managed by the care team during treatment. Seizures, confusion and muscle twitching or jerking are uncommon but are the side effects this drug is best known for. They happen most often in people with a brain condition, a history of seizures or reduced kidney function, and especially when the dose is too high for the kidneys. Tell the nurse or doctor right away about any twitching, confusion or seizure. Severe watery or bloody diarrhea can signal a C. difficile infection of the colon, which antibiotics can trigger even weeks to two months after treatment ends. Contact a provider promptly if it develops, including after you have gone home. A serious allergic reaction, with trouble breathing, swelling of the face or throat or widespread hives, needs emergency treatment immediately.
Before treatment starts, tell the team about any past allergic reaction to penicillins, cephalosporins, carbapenems or other antibiotics. People with a penicillin allergy have had severe reactions to related antibiotics like imipenem, so the team weighs that history in choosing a drug. A known allergy to any ingredient in the product rules it out. The most important interaction is with valproic acid or divalproex, medicines often used to control seizures. Imipenem and cilastatin can drop valproate levels so far that seizures break through, and raising the valproate dose may not fix it, so a different antibiotic is usually chosen. Ganciclovir, an antiviral, has been linked to seizures when combined with it, and probenecid, a gout medicine, raises imipenem levels and is not recommended alongside it. Let the team know about any seizure disorder, stroke or other brain condition, and about kidney disease. Information on use in pregnancy and breastfeeding is limited, so the decision rests on how serious the infection is and what alternatives exist.
Imipenem and cilastatin is usually part of hospital care for a serious infection. It is common to feel better early in treatment, but the full course matters: stopping early can let the infection return and encourages resistant bacteria. The team often starts it before lab results are back and may switch to a narrower antibiotic once tests show which bacteria are involved and what they respond to. During a longer course, blood tests check kidney and liver function and blood counts, and the IV site is watched for irritation. Treatment length depends on the type and site of infection and how quickly it responds.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Cilastatin, what you've noticed, or ask the community a question.